| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accelerating the development of a safe and effective HIV vaccine: HIV vaccine case study for the Decade of Vaccines
|
Koff, Wayne C.
|
|
2013
|
31 |
S2 |
p. B204-B208
nvt p.
|
artikel
|
| 2 |
A global regulatory science agenda for vaccines
|
Elmgren, Lindsay
|
|
2013
|
31 |
S2 |
p. B163-B175
nvt p.
|
artikel
|
| 3 |
Applying an equity lens in the Decade of Vaccines
|
Brearley, Lara
|
|
2013
|
31 |
S2 |
p. B103-B107
nvt p.
|
artikel
|
| 4 |
Case study for a vaccine against leishmaniasis
|
Alvar, Jorge
|
|
2013
|
31 |
S2 |
p. B244-B249
nvt p.
|
artikel
|
| 5 |
Civil society organizations, the implementing partners of the Global Vaccine Action Plan
|
Thacker, Naveen
|
|
2013
|
31 |
S2 |
p. B97-B102
nvt p.
|
artikel
|
| 6 |
Delivering the promise of the Decade of Vaccines: Opportunities and challenges in the development of high quality new vaccines
|
Keith, Jacqueline A.
|
|
2013
|
31 |
S2 |
p. B184-B193
nvt p.
|
artikel
|
| 7 |
Desirability and feasibility of a vaccine against cytomegalovirus
|
Griffiths, Paul
|
|
2013
|
31 |
S2 |
p. B197-B203
nvt p.
|
artikel
|
| 8 |
Developing Countries Vaccine Manufacturers Network: Doing good by making high-quality vaccines affordable for all
|
Pagliusi, Sonia
|
|
2013
|
31 |
S2 |
p. B176-B183
nvt p.
|
artikel
|
| 9 |
Editorial
|
Alonso, Pedro L.
|
|
2013
|
31 |
S2 |
p. B3-B4
nvt p.
|
artikel
|
| 10 |
Editorial Board
|
|
|
2013
|
31 |
S2 |
p. CO2-
1 p.
|
artikel
|
| 11 |
Effective vaccine safety systems in all countries: A challenge for more equitable access to immunization
|
Amarasinghe, Ananda
|
|
2013
|
31 |
S2 |
p. B108-B114
nvt p.
|
artikel
|
| 12 |
Enabling implementation of the Global Vaccine Action Plan: Developing investment cases to achieve targets for measles and rubella prevention
|
Thompson, Kimberly M.
|
|
2013
|
31 |
S2 |
p. B149-B156
nvt p.
|
artikel
|
| 13 |
Foreword
|
Berkley, Seth
|
|
2013
|
31 |
S2 |
p. B1-B2
nvt p.
|
artikel
|
| 14 |
Global support for new vaccine implementation in middle-income countries
|
Kaddar, Miloud
|
|
2013
|
31 |
S2 |
p. B81-B96
nvt p.
|
artikel
|
| 15 |
Global Vaccine Action Plan
|
|
|
2013
|
31 |
S2 |
p. B5-B31
nvt p.
|
artikel
|
| 16 |
Group A streptococcal vaccines: Paving a path for accelerated development
|
Dale, James B.
|
|
2013
|
31 |
S2 |
p. B216-B222
nvt p.
|
artikel
|
| 17 |
Malaria vaccine R&D in the Decade of Vaccines: Breakthroughs, challenges and opportunities
|
Birkett, Ashley J.
|
|
2013
|
31 |
S2 |
p. B233-B243
nvt p.
|
artikel
|
| 18 |
Measuring government commitment to vaccination
|
Glassman, Amanda
|
|
2013
|
31 |
S2 |
p. B32-B42
nvt p.
|
artikel
|
| 19 |
Moving forward with strengthening routine immunization delivery as part of measles and rubella elimination activities
|
Fields, Rebecca
|
|
2013
|
31 |
S2 |
p. B115-B121
nvt p.
|
artikel
|
| 20 |
New vaccine introductions: Assessing the impact and the opportunities for immunization and health systems strengthening
|
Wang, Susan A.
|
|
2013
|
31 |
S2 |
p. B122-B128
nvt p.
|
artikel
|
| 21 |
Preventive vaccines for tuberculosis
|
Evans, Thomas G.
|
|
2013
|
31 |
S2 |
p. B223-B226
nvt p.
|
artikel
|
| 22 |
Projections of costs, financing, and additional resource requirements for low- and lower middle-income country immunization programs over the decade, 2011–2020
|
Gandhi, Gian
|
|
2013
|
31 |
S2 |
p. B137-B148
nvt p.
|
artikel
|
| 23 |
Strategic priorities for respiratory syncytial virus (RSV) vaccine development
|
Anderson, L.J.
|
|
2013
|
31 |
S2 |
p. B209-B215
nvt p.
|
artikel
|
| 24 |
Strategies to advance vaccine technologies for resource-poor settings
|
Kristensen, Debra
|
|
2013
|
31 |
S2 |
p. B157-B162
nvt p.
|
artikel
|
| 25 |
The estimated mortality impact of vaccinations forecast to be administered during 2011–2020 in 73 countries supported by the GAVI Alliance
|
Lee, Lisa A.
|
|
2013
|
31 |
S2 |
p. B61-B72
nvt p.
|
artikel
|
| 26 |
The Human Hookworm Vaccine
|
Hotez, Peter J.
|
|
2013
|
31 |
S2 |
p. B227-B232
nvt p.
|
artikel
|
| 27 |
The imperative for stronger vaccine supply and logistics systems
|
Zaffran, Michel
|
|
2013
|
31 |
S2 |
p. B73-B80
nvt p.
|
artikel
|
| 28 |
The need and challenges for development of an Epstein-Barr virus vaccine
|
Cohen, Jeffrey I.
|
|
2013
|
31 |
S2 |
p. B194-B196
nvt p.
|
artikel
|
| 29 |
The need for targeted implementation research to improve coverage of basic vaccines and introduction of new vaccines
|
Arora, Narendra K.
|
|
2013
|
31 |
S2 |
p. B129-B136
nvt p.
|
artikel
|
| 30 |
Vaccine development and deployment: Opportunities and challenges in India
|
Gupta, Sanjukta Sen
|
|
2013
|
31 |
S2 |
p. B43-B53
nvt p.
|
artikel
|
| 31 |
Vaccine research, development, and innovation in Brazil: A translational science perspective
|
Homma, Akira
|
|
2013
|
31 |
S2 |
p. B54-B60
nvt p.
|
artikel
|
Tijdschrift beschrijving